| URL: | http://galns.mutdb.org |
| Full name: | GALNS Mutation Database |
| Description: | GALNS is a molecular testing locus-specific database for N-acetylgalactosamine-6-sulfatase (GALNS) (MPS IVA, Morquio A, Morquio A Syndrome, Mucopolysaccharidosis IVA, OMIM ID #253000). The purpose of this LSDB is to provide locus-specific information on mutations identified in the gene GALNS. Mutations will be curated as either pathogenic, non-pathogenic or as variants of unknown significance. If the mutation reported in this database has been described in a publication, the pubmed ID will be provided. Unpublished mutations can be submitted, however, will be listed as unpublished mutation. Mutations that you submit will not appear in the database until our curators evaluate them. |
| Year founded: | 2014 |
| Last update: | |
| Version: | |
| Accessibility: |
Accessible
|
| Country/Region: | United States |
| Data type: | |
| Data object: | |
| Database category: | |
| Major species: | |
| Keywords: |
| University/Institution: | BioMarin Pharmaceutical Inc |
| Address: | BioMarin Pharmaceutical Inc., Novato, California |
| City: | Novato |
| Province/State: | |
| Country/Region: | United States |
| Contact name (PI/Team): | Nicole Miller |
| Contact email (PI/Helpdesk): | NMiller@bmrn.com |
|
Morquio A syndrome-associated mutations: a review of alterations in the GALNS gene and a new locus-specific database. [PMID: 25137622]
Morquio A syndrome (mucopolysaccharidosis IVA) is an autosomal recessive disorder that results from deficient activity of the enzyme N-acetylgalactosamine-6-sulfatase (GALNS) due to alterations in the GALNS gene, which causes major skeletal and connective tissue abnormalities and effects on multiple organ systems. The GALNS alterations associated with Morquio A are numerous and heterogeneous, and new alterations are continuously identified. To aid detection and interpretation of GALNS alterations, from previously published research, we provide a comprehensive and up-to-date listing of 277 unique GALNS alterations associated with Morquio A identified from 1,091 published GALNS alleles. In agreement with previous findings, most reported GALNS alterations are missense changes and even the most frequent alterations are relatively uncommon. We found that 48% of patients are assessed as homozygous for a GALNS alteration, 39% are assessed as heterozygous for two identified GALNS alterations, and in 13% of patients only one GALNS alteration is detected. We report here the creation of a locus-specific database for the GALNS gene (http://galns.mutdb.org/) that catalogs all reported alterations in GALNS to date. We highlight the challenges both in alteration detection and genotype-phenotype interpretation caused in part by the heterogeneity of GALNS alterations and provide recommendations for molecular testing of GALNS. |